About Noubar Afeyan
  • Noubar Afeyan is the founder and CEO of Cambridge, Mass. life sciences innovation firm Flagship Pioneering.
  • He's also the chairman and cofounder of biotech firm Moderna, known for its Covid-19 vaccine which was authorized by the U.S. FDA in December 2020.
  • Afeyan has helped start more than 70 public and private healthcare and life sciences companies over the course of his career.
  • Born in Beirut, Lebanon, in 1962 to Armenian parents, he and his family fled the Lebanese Civil War to move to Montreal in 1975.
  • Beyond his stake in Moderna, he also owns shares in more than a dozen publicly traded biotech companies in the U.S.
Wealth History
HOVER TO REVEAL NET WORTH BY YEAR

Forbes Lists

#212
Forbes 400 (2021)Dropped off in 2022
Personal Stats
Age
61
Source of Wealth
Biotech, Self Made
Self-Made Score
10
Philanthropy Score
1
Residence
Lexington, Massachusetts
Citizenship
United States
Marital Status
Married
Education
Ph.D, Massachusetts Institute of Technology; Bachelor of Science, McGill University
Did you know
Afeyan is a lecturer at Harvard Business School and also taught at MIT's Sloan School of Management from 2000 to 2016.
In 2014 he helped launch UWC Dilijan, an international boarding school in the town of Dilijan in the mountains of northern Armenia.
In Their Own Words

What keeps you from innovating is being comfortable. If you're an immigrant, then you're used to being out of your comfort zone.

Noubar Afeyan
Related People & Companies
Moderna
Moderna
Holds stake in Moderna
View Profile
Robert Langer
Robert Langer
Business Associate
View Profile
Seo Jung-jin
Seo Jung-jin
Related by origin of wealth: Biotech
View Profile

More on Forbes

Sep 4, 2020

Why Are Moderna Insiders Selling So Many Shares?

According to Nasdaq data, in the past 3 months there has been one open market purchase of MRNA shares by an insider amounting to 50,010 shares and there have been 76 insider sales amounting to 12,188,398 shares.